MCRB
Price
$0.77
Change
+$0.03 (+4.05%)
Updated
Jan 17 closing price
Capitalization
131.02M
52 days until earnings call
OTLK
Price
$2.23
Change
+$0.04 (+1.83%)
Updated
Jan 17 closing price
Capitalization
55.54M
Ad is loading...

MCRB vs OTLK

Header iconMCRB vs OTLK Comparison
Open Charts MCRB vs OTLKBanner chart's image
Seres Therapeutics
Price$0.77
Change+$0.03 (+4.05%)
Volume$830.26K
Capitalization131.02M
Outlook Therapeutics
Price$2.23
Change+$0.04 (+1.83%)
Volume$1.07M
Capitalization55.54M
MCRB vs OTLK Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCRB vs. OTLK commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Hold and OTLK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MCRB: $0.77 vs. OTLK: $2.23)
Brand notoriety: MCRB and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 29% vs. OTLK: 40%
Market capitalization -- MCRB: $131.02M vs. OTLK: $55.54M
MCRB [@Biotechnology] is valued at $131.02M. OTLK’s [@Biotechnology] market capitalization is $55.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileOTLK’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • OTLK’s FA Score: 0 green, 5 red.
According to our system of comparison, both MCRB and OTLK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 2 TA indicator(s) are bullish while OTLK’s TA Score has 3 bullish TA indicator(s).

  • MCRB’s TA Score: 2 bullish, 4 bearish.
  • OTLK’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, OTLK is a better buy in the short-term than MCRB.

Price Growth

MCRB (@Biotechnology) experienced а -9.11% price change this week, while OTLK (@Biotechnology) price change was -5.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

MCRB is expected to report earnings on Apr 30, 2025.

OTLK is expected to report earnings on May 15, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRB($131M) has a higher market cap than OTLK($55.5M). OTLK YTD gains are higher at: 17.989 vs. MCRB (-7.653). MCRB has more cash in the bank: 66.8M vs. OTLK (19.7M). OTLK has less debt than MCRB: OTLK (44.7M) vs MCRB (93.6M).
MCRBOTLKMCRB / OTLK
Capitalization131M55.5M236%
EBITDA-51.72MN/A-
Gain YTD-7.65317.989-43%
P/E RatioN/AN/A-
Revenue126MN/A-
Total Cash66.8M19.7M339%
Total Debt93.6M44.7M209%
FUNDAMENTALS RATINGS
MCRB vs OTLK: Fundamental Ratings
MCRB
OTLK
OUTLOOK RATING
1..100
5420
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8964
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (56) in the Biotechnology industry is in the same range as OTLK (86). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

MCRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

MCRB's SMR Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that MCRB’s stock grew similarly to OTLK’s over the last 12 months.

OTLK's Price Growth Rating (64) in the Biotechnology industry is in the same range as MCRB (89). This means that OTLK’s stock grew similarly to MCRB’s over the last 12 months.

OTLK's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MCRB (100). This means that OTLK’s stock grew similarly to MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBOTLK
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
82%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with RIGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
+4.41%
RIGL - MCRB
38%
Loosely correlated
+16.02%
ATNM - MCRB
37%
Loosely correlated
+14.75%
OTLK - MCRB
32%
Poorly correlated
+1.83%
ARCT - MCRB
29%
Poorly correlated
-1.29%
BMEA - MCRB
28%
Poorly correlated
-2.09%
More

OTLK and

Correlation & Price change

A.I.dvisor tells us that OTLK and MCRB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLK and MCRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+1.83%
MCRB - OTLK
32%
Poorly correlated
+4.41%
VIR - OTLK
31%
Poorly correlated
+0.60%
PASG - OTLK
30%
Poorly correlated
N/A
STRO - OTLK
30%
Poorly correlated
+8.65%
CRSP - OTLK
30%
Poorly correlated
+0.57%
More